Construction and characterization of monoclonal antibodies specific to Epstein-Barr virus latent membrane protein 1

Journal of Immunological Methods

Volumn 287, Issue 1-2, 2004, Pages 21-30

  Fang, Chih Yeu ^a   Chang, Yu Sun ^b   Chow, Kai Ping ^b   Yu, Jau Song ^b   Chang, Hwan You ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

5 bromo 4 chloro 3 indolyl phosphate; BCIP; DMEM; Dulbecco's modified Eagle's medium; EBV; ELISA; Enzyme linked immunosorbent assay; Epstein Barr virus; FBS; Fetal bovine serum; FITC; Fluorescein isothiocyanate; LMP 1; Monoclonal antibody; Quantitative ELISA

Indexed keywords

EPITOPE; LATENT MEMBRANE PROTEIN 1; MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN DETECTION; ANTIGEN RECOGNITION; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; FEMALE; FLUORESCENCE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; LYMPHOID CELL; MOUSE; NONHUMAN; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROTEIN DOMAIN; QUANTITATIVE ANALYSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CELL LINE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, B-LYMPHOCYTE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLUTATHIONE TRANSFERASE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN ISOTYPES; MICE; RECOMBINANT FUSION PROTEINS; SENSITIVITY AND SPECIFICITY; TRANSFECTION; VIRAL MATRIX PROTEINS;

BOVINAE; CICONIIFORMES; HUMAN HERPESVIRUS 4;

EID: 1942424265     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.01.021     Document Type: Article

References (36)

1. Baichwal V.R., Sugden B. Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus. J. Virol. 61:1987;866.
2. Baichwal V.R., Sugden B. Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene. 2:1988;461.
3. Chen M.L., Tsai C.N., Liang C.L., Shu C.H., Huang C.R., Sulitzeanu D., Liu S.T., Chang Y.S. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene. 7:1992;2131.
4. Chi L.M., Yu J.S., Chang Y.S. Identification of protein kinase CK2 as a potent kinase of Epstein-Barr virus latent membrane protein 1. Biochem. Biophys. Res. Commun. 294:2002;586.
5. Clausse B., Fizazi K., Walczak V., Tetaud C., Wiels J., Tursz T., Busson P. High concentration of the EBV latent membrane protein 1 in glycosphingolipid-rich complexes from both epithelial and lymphoid cells. Virology. 228:1997;285.
6. Dawson C.W., Rickinson A.B., Young L.S. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature. 344:1990;777.
7. Dawson C.W., Eliopoulos A.G., Blake S.M., Barker R., Young L.S. Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells. Virology. 272:2000;204.
8. Dukers D.F., Meij P., Vervoort M.B., Vos W., Scheper R.J., Meijer C.J., Bloemena E., Middeldorp J.M. Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J. Immunol. 165:2000;663.
9. Eliopoulos A.G., Gallagher N.J., Blake S.M., Dawson C.W., Young L.S. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J. Biol. Chem. 274:1999;16085.
10. Erickson K.D., Martin J.M. Early detection of the lytic LMP-1 protein in EBV-infected B-cells suggests its presence in the virion. Virology. 234:1997;1.
11. Erickson K.D., Martin J.M. The late lytic LMP-1 protein of Epstein-Barr virus can negatively regulate LMP-1 signaling. J. Virol. 74:2000;1057.
12. Fahraeus R., Rymo L., Rhim J.S., Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature. 345:1990;447.
13. Fries K.L., Miller W.E., Raab-Traub N. The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex. Virology. 264:1999;159.
14. Gires O., Kohlhuber F., Kilger E., Baumann M., Kieser A., Kaiser C., Zeidler R., Scheffer B., Ueffing M., Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J. 18:1999;3064.
15. Gulley M.L. Molecular diagnosis of Epstein-Barr virus-related diseases. J. Mol. Diagnostics. 3:2001;1.
16. Hanto D.W., Frizzera G., Gajl-Peczalska K.J., Simmons R.L. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation. 39:1985;461.
17. Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang F., Longnecker R., Kieff E., Rickinson A. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell. 65:1991;1107.
18. Henle G., Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int. J. Cancer. 17:1976;1.
19. Izumi K.M., Cahir McFarland E.D., Riley E.A., Rizzo D., Chen Y., Kieff E. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation. J. Virol. 73:1999;9908.
20. Kaye K.M., Izumi K.M., Mosialos G., Kieff E. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues. J. Virol. 69:1995;675.
21. Klein G. Epstein-Barr virus strategy in normal and neoplastic B cells. Cell. 77:1994;791.
22. Laherty C.D., Hu H.M., Opipari A.W., Wang F., Dixit V.M. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J. Biol. Chem. 267:1992;24157.
23. Liebowitz D. Nasopharyngeal carcinoma: the Epstein-Barr virus association. Semin. Oncol. 21:1994;376.
24. Liebowitz D., Kopan R., Fuchs E., Sample J., Kieff E. An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes. Mol. Cell. Biol. 7:1987;2299.
25. Liu Q.Y., Summers W.C. Novel 12-O-tetradecanoylphorbol-13-acetate- responsive elements in the upstream sequence of the MS gene promoter of Epstein-Barr virus. J. Virol. 63:1989;5062.
26. Lones M.A., Shintaku I.P., Weiss L.M., Thung S.N., Nichols W.S., Geller S.A. Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus. Hum. Pathol. 28:1997;533.
27. Macsween K.F., Crawford D.H. Epstein-Barr virus - recent advances. Lancet, Infect. Dis. 3:2003;131.
28. Mann K.P., Thorley-Lawson D. Posttranslational processing of the Epstein-Barr virus-encoded p63/LMP protein. J. Virol. 61:1987;2100.
29. Mosialos G., Birkenbach M., Yalamanchili R., VanArsdale T., Ware C., Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 80:1995;389.
30. Osato T., Imai S. Epstein-Barr virus and gastric carcinoma. Semin. Cancer Biol. 7:1996;175.
31. Richison A.B., Kieff E. Fields B.N., Knipe D.M., Howley P.M., Chanock R.M., Melnick J.L., Monath T.P., Roizman B., Straus S.E. Fields' Virology. Third edition:1996;2397 Lippincott-Raven Publishers.
32. Wang D., Liebowitz D., Kieff E. The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts. J. Virol. 62:1988;2337.
33. Wang S., Rowe M., Lundgren E. Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines. Cancer Res. 56:1996;4610.
34. Wilson J.B., Weinberg W., Johnson R., Yuspa S., Levine A.J. Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell. 61:1990;1315.
35. Wutzler P., Farber I., Sauerbrei A., Helbig B., Wutke K., Rudiger K.D., Scheibner K., Brichacek B., Vonka V. Demonstration of Epstein-Barr virus in malignant non-Hodgkin's lymphomas. Oncology. 43:1986;224.
36. Young L.S., Dawson C.W., Clark D., Rupani H., Busson P., Tursz T., Johnson A., Rickinson A.B. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J. Gen. Virol. 69(Pt. 5):1988;1051.